Developer of a new class of synthetic anti-infectives, Recce Pharmaceuticals has been granted its Family 4 patent in Hong Kong, extending protection through to 2041.
The India Gentamycin market is driven by rising bacterial infections and antimicrobial resistance, supported by government healthcare improvements. Despite toxicity concerns, the move towards ...
ID, A NATIONAL UNIVERSITY OF SINGAPORE LED TRIAL NETWORK, IN PARTNERSHIP WITH BIOVERSYS Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Panel of ...
The growing incidence of multidrug-resistant (MDR) or extensively-drug resistant (XDR) bacteria is an emerging challenge in modern medicine. Constant ...
In natural environments, bacteria rarely live as free-swimming cells but are attached to surfaces as biofilms in medical ...
Emirates News Agency on MSN
Pfizer introduces novel treatment option in UAE against Gram-negative bacterial infections
Pfizer announced the introduction of a novel treatment in the United Arab Emirates for adult patients with serious Gram-negative bacterial infections in the United Arab Emirates. This milestone marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback